Sign inJoin waitlistJoin the waitlist

BL

Bart Leroy

Ophthalmology

Credentials: ·

History

Ophthalmology

Research

Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
The Lancet · 2017 · 1,570 citations
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
The Lancet · 2009 · 694 citations
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1…
The Lancet · 2016 · 389 citations

José-Alain Sahel
12 papers
Albert Maguire
11 papers
EP
Eric Pierce
10 papers
Stephen Russell
9 papers
Tomas Aleman
8 papers · 2 as a resident
AM
Anthony Moore
7 papers
Jacque Duncan
7 papers
Arlene Drack
6 papers
BL
Bart Loeys
6 papers
JH
John Heckenlively
6 papers
Katherine High
6 papers
MP
Mark Pennesi
6 papers